Overview

Detailed Summary

GKB Ophthalmics specializes in manufacturing and exporting unfinished ophthalmic lenses from Goa, India.
The company has robust production capabilities with an installed capacity of 3 million lenses per annum.
A strategic move was establishing a subsidiary in Germany, aiding market expansion into Europe.
GKB started producing CR 39 lenses in 2007, indicating product line diversification.
Recent ventures into producing Hi-Index lenses faced financial challenges, prompting reconsideration of expansion strategies.

Sector: Healthcare Equipment & Supplies
Industry: Medical Equipment & Supplies
Market Cap: 32 Cr
Volatility: High Risk
P/E Ratio: 26.4
Industry P/E: 42.3
PEG Ratio: -0.1
P/B Ratio: 0.6
52W High: 91.70
52W Low: 45.25

Sales CAGR

1Y: 23.50%
3Y: 6.58%
5Y: 5.08%
10Y: -0.09%

Profit CAGR

1Y: -137.58%
3Y: —
5Y: —
10Y: —

ROE

TTM: 5.53%
3Y: -5.33%
5Y: -3.00%
10Y: -1.23%

ROCE

TTM: 11.74%
3Y: -1.69%
5Y: 0.33%
10Y: 2.42%

Technicals

‌

Forecasts

Peers

Healthcare Healthcare Medical Equipment & Supplies

Symbol	Watchlist	Price	Market Cap	P/E	P/B	Div Yield (%)	ROE (%)	ROCE (%)	ROA (%)
SHREEPAC		140.00	53 Cr	16.72	2.95	0.00	17.36	22.18	12.21
AMKAY		54.00	47 Cr	20.23	1.77	0.00	8.76	11.99	6.93
KMSMEDI		132.80	44 Cr	182.58	5.27	0.00	2.95	4.81	2.27
GKB		63.60	32 Cr	26.29	0.60	0.00	5.53	11.74	2.29
GML		19.30	29 Cr	8.56	0.85	3.89	8.47	11.15	7.01
CSURGSU		73.04	27 Cr	-12.06	1.00	0.00	-7.72	2.14	-2.77
TRANSPACT		190.35	8 Cr	77.30	17.13	0.00	20.02	17.04	13.70
Median: 7 Co.	—	73.04	32 Cr	20.23	1.77	0.00	8.47	11.74	6.93

Financial Statements

AI Powered Summary

Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.

Ask AI

Consolidated Quarterly Results (in ₹ Crores)

View Standalone

Total Figures

QoQ Changes

Total Figures

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Sales	24	22	26	26	26	31	32	30	57	30
Expenses	25	22	25	26	27	34	32	27	55	27
Operating Profit	-0.49	0.01	1.05	-0.06	-0.91	-2.86	0.81	3.05	1.36	3.11
OPM %	-2.04	0.05	4.04	-0.23	-3.53	-9.22	2.51	10.11	2.39	10.44
Other Income	0.35	0.50	0.28	0.23	0.45	0.35	0.20	0.34	0.87	-0.71
Interest	0.44	0.57	0.55	0.55	0.63	0.63	0.77	0.66	0.73	0.52
Depreciation	0.73	0.72	0.76	0.77	0.77	0.80	0.80	0.82	0.82	0.80
Profit Before Tax	-1.31	-0.79	0.01	-1.15	-1.86	-3.93	-0.56	1.91	0.68	1.08
Tax %	0.00	-25.32	600.00	-5.22	-2.69	-4.83	-14.29	3.66	-4.41	-3.70
Net Profit	-1.31	-0.99	-0.04	-1.20	-1.91	-4.13	-0.64	1.84	0.71	1.12
EPS in Rs	-2.48	-1.81	-0.50	-2.41	-4.03	-7.03	-2.02	3.17	0.08	0.38

Consolidated Profit Loss (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
Sales	76	78	57	59	57	71	75	88	109	109
Expenses	75	77	56	56	55	66	72	88	112	112
Operating Profit	1.83	1.34	1.14	2.14	2.31	4.85	3.69	0.58	-2.78	-2.78
OPM %	2.39	1.72	2.00	3.65	4.07	6.83	4.88	0.66	-2.55	-2.55
Other Income	3.83	0.49	2.30	1.11	1.93	1.25	0.96	1.45	1.51	1.31
Interest	1.29	1.27	1.48	1.46	2.03	1.48	1.67	1.90	2.37	2.36
Depreciation	1.43	1.70	3.54	3.62	3.14	2.67	2.83	2.90	3.09	3.10
Profit Before Tax	2.94	-1.14	-1.58	-1.84	-0.93	1.95	0.14	-2.78	-6.73	-6.93
Tax %	12.12	14.58	30.10	0.00	19.40	0.12	16.57	-7.43	-5.25	-5.05
Net Profit	2.59	-0.97	-1.10	-1.84	-0.75	1.94	0.12	-2.98	-7.08	-7.28
EPS in Rs	—	—	-2.54	-3.94	-1.79	2.52	-0.33	-5.57	-13.97	1.61
Dividend Payout %	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	—

Consolidated Balance Sheet (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	4.15	4.15	4.15	4.64	5.04	5.04	5.04	5.04	5.04	5.04
Reserves	41	43	41	50	54	58	58	58	55	47
Borrowings	7.15	7.12	9.88	14	15	12	12	11	11	14
Other Liabilities	17	28	28	25	28	32	35	38	43	59
Total Liabilities	69	82	83	93	102	107	110	112	115	125
Fixed Assets	13	18	18	26	26	24	23	19	18	17
CWIP	0.57	0.57	0.24	0.00	0.00	1.23	3.41	3.95	3.91	3.91
Investments	10	3.48	0.37	0.54	1.15	2.08	1.97	1.89	1.83	2.01
Other Assets	46	60	64	67	75	80	82	87	91	102
Total Assets	69	82	83	93	102	107	110	112	115	125

Consolidated Cash Flows (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity	-11	-3.41	-2.66	3.92	3.27	6.86	5.07	-2.77	4.22	-3.43
Cash from Investing Activity	15	3.75	1.34	-9.89	-3.73	-17	-3.52	1.43	-1.71	2.55
Cash from Financing Activity	-2.83	-1.33	1.37	13	4.30	2.77	-1.66	-2.19	-1.64	0.67
Net Cash Flow	0.40	-0.99	0.04	7.16	3.84	-7.15	-0.12	-3.53	0.87	-0.21

Shareholdings

Shareholding History

Quarterly

Yearly

Quarterly

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Promoters	59.18%	50.86%	50.88%	50.93%	50.95%	50.95%	50.98%	50.99%	51.06%	51.06%	51.13%	51.13%
FIIs	1.79%	1.79%	1.79%	1.79%	1.79%	1.79%	1.79%	1.79%	1.79%	1.79%	1.79%	1.79%
DIIs	0.01%	0.01%	0.01%	0.01%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Public	39.02%	47.34%	47.32%	47.27%	47.27%	47.27%	47.23%	47.23%	47.16%	47.16%	47.09%	47.09%
Total Shareholders	2,030	2,115	2,233	2,370	2,690	2,510	2,539	2,538	2,550	2,601	2,661	2,634

Market Transactions

Unlock more with professional

Real-time bulk & block deal transactions
Export transaction data for analysis

Projection

Documents

Presentations

Concalls

Reports

Presentations

No documents found!

Actions

Action Type

‌
‌

Announcements

Last 7 days

Newest

Sentiment

Sorry, no results found!

AI Mode

Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.